黄宁华

助理研究员
hnh@bjmu.edu.cn
北京市海淀区学院路38号
全球信誉最好的网赌软件

个人简介

1、教育经历：

2010/9-2015/7，全球信誉最好的网赌软件，劳动卫生与环境卫生学，博士；

2002/9-2005/7，中国疾病预防控制中心，环境卫生与劳动卫生，硕士；

1995/9-2000/7，华中科技大学同济医学院，妇幼卫生专业，本科。

2、科研与学术工作经历：

2005/07-至今，澳门十大娱乐网站平台卫生检验学系，助理研究员；

2000/07-2002/09，广西区妇幼保健院，住院医师。

从事疫苗评价相关研究，参加过传染病防治课题及疫苗评价等多项国家级、省部级课题研究，同时为中华预防医学会疫苗免疫分会青年委员会委员。中国预防医学会促进消除病毒性肝炎工作委员会秘书。

主要研究方向

1. 传染病防控策略

2. 疫苗评价。

3. 公共卫生领域中有机物质分析。

代表性科研项目

1. 北京市自然科学基金-海淀原始创新联合基金项目，新型冠状病毒病流行病学特征、疫苗效果和综合防控策略研究， L222028，2023-01至2025-12，主持。

2. 国家社会科学基金项目，疫苗应急接种社会动员与韧性治理的双元模式研究：疫情变动下态度扰动与信任脆弱为视角，2023.01-2025.12，参与

3. 科技部国家重点研发计划，“新冠灭活疫苗应用与免疫策略2021YFC2301604 ，2021-12 至 2024-11，参与。

4. 北京市自然科学基金面上项目，2122051，无机指纹与常见致病菌快速检定，参与。

5. 国家自然科学基金面上项目，30972434，“同体血、尿、发、脏器铅指纹差异现象”成因研究，参与。

6. 科技部重大专项，30972434，中草药有毒重金属残留检测方法及标准物质研制，参与。

10篇代表性论文

1. Huang N, Wang C, Han B, Zhao T, Liu B, Chen L, Xie M, Zheng H, Zhang S, Wang Y, Juan D, Liu Y, Lu Q, Cui F. Change in willingness to COVID-19 vaccination in China: Two online surveys during the pandemic. J Med Virol. 2022 Nov;94(11):5271-5278.

2. Huang N, Cao B, Brietzke E, Park C, Cha D, Pan Z, Zhu J, Liu Y, Xie Q, Zeng J, McIntyre RS, Wang J, Yan L. A pilot case-control study on the association between N-acetyl derivatives in serum and first-episode schizophrenia. Psychiatry Res. 2019 Feb;272:36-41.

3. Zhang S, Zhao T, Chen L, Xie M, Lu QB, Du J, Zeng J, Huang N, Liu Y, Wang C, Cui F. Analysis of deaths following yeast-derived hepatitis B vaccination of infants, China, January 2013 to December 2020. Front Public Health. 2023 Jun 16;11:1170483.

4. Liu M, Zhao T, Mu Q, Zhang R, Liu C, Xu F, Liang L, Zhao L, Zhao S, Cai X, Wang M, Huang N, Feng T, Lei S, Yang G, Cui F. Immune-Boosting Effect of the COVID-19 Vaccine: Real-World Bidirectional Cohort Study. JMIR Public Health Surveill. 2023 Oct 11;9:e47272.

5. Wang C, Liu B, Zhang S, Huang N, Zhao T, Lu QB, Cui F. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review. J Med Virol. 2023 Jan;95(1):e28118.

6. Zhang S, Wang C, Liu B, Lu QB, Shang J, Zhou Y, Jia J, Xu X, Rao H, Han B, Zhao T, Chen L, Xie M, Cui J, Du J, Zeng J, Huang N, Liu Y, Zhang L, Zhuang H, Cui F. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation. Lancet Reg Health West Pac. 2023 Mar 9;35:100738.

7. Wang C, Huang N, Lu QB, Black S, Liang X, Cui F. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China. Front Immunol. 2022 Sep 30;13:956473.

8. Wang C, Han B, Zhao T, Liu H, Liu B, Chen L, Xie M, Liu J, Zheng H, Zhang S, Wang Y, Huang N, Du J, Liu YQ, Lu QB, Cui F. Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study[J]. Vaccine, 2021, 39(21):2833-2842.

9. Cao B, Sun XY, Zhang CB, Yan JJ, Zhao QQ, Yang SY, Yan LL, Huang NH, Zeng J, Liao JY, Wang JY. Association between B vitamins and schizophrenia: A population-based case-control study.Psychiatry Res. 2018 Jan; 259:501-505.

10. Ma JH, Sun XY, Guo TJ, Barot E, Wang DF, Yan LL, Ni DW, Huang NH, Xie Q, Zeng J, Ou-Yang L, Liu YQ, Lu QB Association on DISC1 SNPs with schizophrenia risk: A meta-analysis.Psychiatry Res. 2018 Sep 23;270:306-309.